Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05750914
Other study ID # SBBLCIP003
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date January 19, 2024

Study information

Verified date April 2024
Source Sciton
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluation of safety and efficacy of Broadband light treatment


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date January 19, 2024
Est. primary completion date December 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Healthy male or female, 18 years or older - Fitzpatrick skin type I-IV - Has visible signs of moderate to severe skin pigmentation - Willing to not use any other procedure(s) in the treatment area during the study, such as laser- or light-based treatment, non-light-based device treatment such as radiofrequency or ultrasound, injection of botulinum toxin, collagen, hyaluronic acid filler or other dermal filler, chemical peel, or surgical procedure - Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study, and no plans to become pregnant for the duration of the study. (applicable to female subjects only) - Willing to have very limited sun exposure and use an approved sunscreen of SPF 30 or higher on the treatment area every day for the duration of the study, including the follow-up period - Willing to have digital photographs taken of the treatment area and agree to use of photographs for presentation, educational or marketing purposes - Subject must agree to not make any changes in their skin regimen for the duration of the study, including the follow-up period - Subject must be able to read, understand and sign Informed Consent Form - Must be willing to adhere to the treatment and follow-up schedule and post-treatment care instructions Exclusion Criteria: - Fitzpatrick skin type V-VI - Participation in a clinical trial of another device or drug within 6 months prior to enrollment or during the study. - Any type of prior cosmetic treatment to the target area within 3 months of study participation, such as laser or light-based procedures or surgery. - Prior injection of botulinum toxin, collagen, hyaluronic acid filler or other dermal filler in the target area within 1 week of study participation. - History of malignant tumors in the target area. - Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, scars, large moles. - Pregnant and/or breastfeeding (applicable to female subjects only) - Having an infection, dermatitis or a rash in the treatment area. - Significant concurrent illness, such as diabetes mellitus or cardiovascular disease, e.g., uncontrolled hypertension. - Suffering from coagulation disorders or taking prescription anticoagulation medications. - History of keloid scarring, hypertrophic scarring or of abnormal wound healing. - History of immunosuppression/immune deficiency disorders or currently using immunosuppressive medications. - History of vitiligo, eczema, or psoriasis. - History of connective tissue disease, such as systemic lupus erythematosus or scleroderma. - History of seizure disorders due to light. - Any use of medication that is known to increase sensitivity to light according to Investigator's discretion. - History of disease stimulated by heat, such as recurrent herpes simplex and/or herpes zoster (shingles) in the treatment area, unless treatment is conducted following a prophylactic regimen. - History of radiation to the treatment area or undergoing systemic chemotherapy for the treatment of cancer. - History of pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation. - Systemic use of retinoid, such as isotretinoin, or corticosteroid, as applicable, within 6 months of study participation. - Topical use of retinoid, such as isotretinoin, corticosteroid or hydroquinone on the target area within 1 month of participation. - Anytime in life, having have used gold therapy (gold salts) for disorders such as rheumatologic disease or lupus. - Excessively tanned in areas to be treated, or unable/unlikely to refrain from tanning during the study (for example, subject's occupation requires regular sun exposure). - Current smoker or history of smoking within 6 months of study participation. - As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Broadband Light
Broadband Light treatment using standard protocol

Locations

Country Name City State
United States Rochester Dermatologic Surgery Victor New York

Sponsors (1)

Lead Sponsor Collaborator
Sciton

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pigmentation Percent improvement in pigmentation as assessed using digital photographs taken at baseline and 4-6 weeks post treatment 4-6 weeks
Primary Skin texture Percent improvement in skin texture as assessed using digital photographs taken at baseline and 4-6 weeks post treatment 4-6 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05913102 - A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin N/A
Recruiting NCT04539561 - Evaluation of the Efficacy and Safety of PiQo4 for the Treatment of Hand Pigmentation Using 1064nm PSL and 532nm PSL N/A
Recruiting NCT06074276 - The Effects of Almond on Facial Skin Collagen and Wrinkles N/A
Completed NCT05662592 - Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study N/A
Recruiting NCT05847530 - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions N/A
Enrolling by invitation NCT01847066 - Epidermal Delivery of Ani-Aging Ingredients N/A
Completed NCT03065582 - The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects N/A
Completed NCT03565146 - Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions N/A
Completed NCT04493021 - Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions N/A
Terminated NCT02506101 - Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo N/A
Not yet recruiting NCT05160103 - 16-Week Randomized Split-Face Efficacy Study of Cosmetic Formulations in Photoaged Pigmented Skin Subjects N/A
Completed NCT06075641 - Post Gingival Depigmentation Assessment: Comparison of Surgical Stripping vs (Er,Cr:YSGG) Laser N/A
Completed NCT01885091 - Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage Phase 4
Completed NCT05710068 - Effects of RF Microneedle on Photoaging Skin N/A
Completed NCT05304624 - Comparison of Er,Cr:YSGG Laser and Diode Laser in the Treatment of Gingival Melanin Pigmentation N/A
Recruiting NCT04866797 - Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under UV Day Light Exposure N/A
Recruiting NCT04865094 - Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under Long-UVA Exposure N/A
Completed NCT04881058 - Post Market Clinical Follow Up Study to Collect Additional Data and Imaging N/A
Completed NCT03970317 - Safety and Efficacy of Broad Band Light In Motion Treatment N/A